Gene Editing Are patients with a history of MIS-C at increased risk of adverse reactions from COVID-19 vaccination? Posted on January 5, 2023 by Editorial Staff Researchers investigated the reactogenicity of the COVID-19 vaccine in pediatric patients with MIS-C. Share on FacebookTweetFollow us Editorial Staff Incurable liver disease may prove curable STAT+: Biogen shakes up R&D chief role, makes Singhal permanent replacement